115 related articles for article (PubMed ID: 32934777)
1. Correction: Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways.
Yang J; Pei H; Luo H; Fu A; Yang H; Hu J; Zhao C; Chai L; Chen X; Shao X; Wang C; Wu W; Wan L; Ye H; Qiu Q; Peng A; Wei Y; Yang L; Chen L
Oncotarget; 2020 Sep; 11(35):3350-3351. PubMed ID: 32934777
[TBL] [Abstract][Full Text] [Related]
2. Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.
Hu J; Song C; Duan B; Zhang X; Li D; Zhu L; Gao H
Oncotarget; 2018 Jul; 9(58):31311. PubMed ID: 30131857
[TBL] [Abstract][Full Text] [Related]
3. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
Song JM; Anandharaj A; Upadhyaya P; Kirtane AR; Kim JH; Hong KH; Panyam J; Kassie F
Oncotarget; 2016 Sep; 7(36):57752-57769. PubMed ID: 27458163
[TBL] [Abstract][Full Text] [Related]
4. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
Wen J; Fu AF; Chen LJ; Xie XJ; Yang GL; Chen XC; Wang YS; Li J; Chen P; Tang MH; Shao XM; Lu Y; Zhao X; Wei YQ
Int J Cancer; 2009 Jun; 124(11):2709-18. PubMed ID: 19219913
[TBL] [Abstract][Full Text] [Related]
5. Correction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.
Tang B; Qi G; Tang F; Yuan S; Wang Z; Liang X; Li B; Yu S; Liu J; Huang Q; Wei Y; Zhai R; Lei B; Yu H; Jiao X; He S
Oncotarget; 2020 May; 11(19):1797-1798. PubMed ID: 32477467
[TBL] [Abstract][Full Text] [Related]
6. Correction: MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma.
Xiang ZL; Zhao XM; Zhang L; Yang P; Fan J; Tang ZY; Zeng ZC
Oncotarget; 2019 Oct; 10(59):6398-6399. PubMed ID: 31695850
[TBL] [Abstract][Full Text] [Related]
7. Correction: Genipin suppresses colorectal cancer cells by inhibiting the Sonic Hedgehog pathway.
Kim BR; Jeong YA; Na YJ; Park SH; Jo MJ; Kim JL; Jeong S; Lee SY; Kim HJ; Oh SC; Lee DH
Oncotarget; 2018 Jun; 9(47):28796. PubMed ID: 29983897
[TBL] [Abstract][Full Text] [Related]
8. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity.
Hu J; Chen LJ; Liu L; Chen X; Chen PL; Yang G; Hou WL; Tang MH; Zhang F; Wang XH; Zhao X; Wei YQ
Exp Mol Med; 2008 Dec; 40(6):617-28. PubMed ID: 19116447
[TBL] [Abstract][Full Text] [Related]
9. Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
Siu MK; Abou-Kheir W; Yin JJ; Chang YS; Barrett B; Suau F; Casey O; Chen WY; Fang L; Hynes P; Hsieh YY; Liu YN; Huang J; Kelly K
Oncotarget; 2018 Aug; 9(64):32403. PubMed ID: 30190798
[TBL] [Abstract][Full Text] [Related]
10. Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.
Ladju RB; Pascut D; Massi MN; Tiribelli C; Sukowati CHC
Oncotarget; 2018 Feb; 9(16):13101. PubMed ID: 29569656
[TBL] [Abstract][Full Text] [Related]
11. Correction:
Madic J; Jovelet C; Lopez J; André B; Fatien J; Miran I; Honoré A; Mezquita L; Besse B; Lacroix L; Droniou M
Oncotarget; 2019 Feb; 10(13):1345. PubMed ID: 30863495
[TBL] [Abstract][Full Text] [Related]
12. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
13. Correction: MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression.
Hu MH; Ma CY; Wang XM; Ye CD; Zhang GX; Chen L; Wang JG
Oncotarget; 2021 Aug; 12(18):1859-1860. PubMed ID: 34504658
[TBL] [Abstract][Full Text] [Related]
14. Correction: Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Wu YJ; Lu YJ; Liang SM; Liu CC; Chen SC; Wang J; Shyue SK; Liou JY
Oncotarget; 2018 Oct; 9(79):35026. PubMed ID: 30405891
[TBL] [Abstract][Full Text] [Related]
15. Correction: Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
Oncotarget; 2018 Dec; 9(102):37807. PubMed ID: 30701034
[TBL] [Abstract][Full Text] [Related]
16. Correction: BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer.
Shields S; Conroy E; O'Grady T; McGoldrick A; Connor K; Ward MP; Useckaite Z; Dempsey E; Reilly R; Fan Y; Chubb A; Matallanas DG; Kay EW; O'Connor D; McCann A; Gallagher WM; Coppinger JA
Oncotarget; 2019 May; 10(33):3144. PubMed ID: 31139326
[TBL] [Abstract][Full Text] [Related]
17. Correction: The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells.
Wan X; Cheng C; Lin Z; Jiang R; Zhao W; Yan X; Tang J; Yao K; Sun B; Chen Y
Oncotarget; 2022; 13():271-272. PubMed ID: 35111282
[TBL] [Abstract][Full Text] [Related]
18. Correction: IL-17A weakens the antitumor immunity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice.
Wang J; Zhang Y; Yin K; Xu P; Tian J; Ma J; Tian X; Wang Y; Tang X; Xu H; Wang S
Oncotarget; 2022; 13():425. PubMed ID: 35198101
[TBL] [Abstract][Full Text] [Related]
19. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
Singh T; Gupta NA; Xu S; Prasad R; Velu SE; Katiyar SK
Oncotarget; 2015 Aug; 6(25):21268-82. PubMed ID: 26020804
[TBL] [Abstract][Full Text] [Related]
20. Correction: Monitoring
Morán T; Felip E; Bosch-Barrera J; de Aguirre I; Ramirez JL; Mesia C; Carcereny E; Roa D; Sais E; García Y; Blanco R; Sanchez S; Villacorta CR; Queralt C; Velarde JM; Rosell R
Oncotarget; 2019 Apr; 10(26):2576. PubMed ID: 31069018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
